BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9411549)

  • 1. [Atypical serologic patterns in hepatitis B virus infection].
    Muñoz Criado S; Muñoz Bellido JL; García Rodríguez JA
    Rev Clin Esp; 1997 Jul; 197(7):507-11. PubMed ID: 9411549
    [No Abstract]   [Full Text] [Related]  

  • 2. [Atypical profile of markers of hepatitis B and vaccination].
    Velosa J
    Acta Med Port; 1996; 9(7-9):247-51. PubMed ID: 9005705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vaccination and serologic markers of hepatitis B virus infection].
    Salmeron Garcia F; Echevarria Mayo JM
    Rev Sanid Hig Publica (Madr); 1990; 64(3-4):141-50. PubMed ID: 2131596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The serologic markers of hepatitis B virus infection--proper selection and standardized interpretation.
    Caspari G; Gerlich WH
    Clin Lab; 2007; 53(5-6):335-43, 391-400. PubMed ID: 17605409
    [No Abstract]   [Full Text] [Related]  

  • 5. Does hepatitis B serology mean infection or immunity?
    Waring L; Reed C
    Aust Fam Physician; 2000 Feb; 29(2):154-5. PubMed ID: 10743271
    [No Abstract]   [Full Text] [Related]  

  • 6. [The prevalence of serum markers of the hepatitis B virus in the personnel of a general hospital].
    Jaqueti J; Pérez-Piqueras J; Martínez-Hernández D; Blasco Ferrándiz R; Nicolás D; Navarro-Gallar F
    Rev Esp Enferm Dig; 1992 Jul; 82(1):63-5. PubMed ID: 1520557
    [No Abstract]   [Full Text] [Related]  

  • 7. [Differential diagnosis of Hepatitis A, B, C, D and E. Clinical, biochemical and viral serologic criteria. 3: Serology--hepatitis B].
    Eisenburg J
    Fortschr Med; 1995 Jan; 113(1-2):41-2, 45. PubMed ID: 7883265
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevalence of serologic markers of hepatitis B virus in non-hospital health personnel].
    López Martínez RM; Cervera Estrany M; Planells Torres P; Juvé Saumell R
    Med Clin (Barc); 1994 Oct; 103(10):396. PubMed ID: 7983906
    [No Abstract]   [Full Text] [Related]  

  • 9. [Viral marker related to antigen and antibody of hepatitis B virus].
    Arase Y
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():439-42. PubMed ID: 20942098
    [No Abstract]   [Full Text] [Related]  

  • 10. [Epidemiological characteristics of viral hepatitis B in combination with a tuberculous infection in a hospital].
    Ogarkov PI; Korotchenko SI; Tokmakov VS; Zaretskiĭ BV
    Voen Med Zh; 1996 Jul; 317(7):47-50. PubMed ID: 8967042
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis B reverse seroconversion in a patient with well controlled HIV infection: a case report and a review of the literature.
    Schafer JJ; Formella D; Desimone JA
    AIDS; 2015 Jan; 29(2):246-8. PubMed ID: 25532610
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hepatitis B].
    Kashiwagi S
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():236-40. PubMed ID: 12722220
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis B virus reactivation during therapy with etanercept in an HBsAg-negative and anti-HBs-positive patient.
    Montiel PM; Solis JA; Chirinos JA; a Casis B; Sánchez F; Rodríguez S
    Liver Int; 2008 May; 28(5):718-20. PubMed ID: 18433400
    [No Abstract]   [Full Text] [Related]  

  • 14. Cryoglobulinemia and hepatatrophic viruses.
    Baker AL
    Hepatology; 1993 Sep; 18(3):698-700. PubMed ID: 7689532
    [No Abstract]   [Full Text] [Related]  

  • 15. About the relationship between infection and atherosclerosis: the importance of adequate serological markers.
    Vassalle C; Zucchelli GC; Giustini C
    Atherosclerosis; 2004 Nov; 177(1):211-2; author reply 213-4. PubMed ID: 15488886
    [No Abstract]   [Full Text] [Related]  

  • 16. [Occult hepatitis B virus infection in patients treated with chronic hemodialysis].
    Teruel JL; Mateos ML; Fernández Lucas M; Ortuño J
    Nefrologia; 2005; 25(1):83-4. PubMed ID: 15789543
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hepatitis B virus infection in the absence of serological markers or with atypical serological patterns].
    Moreno García M
    Rev Clin Esp; 1997 Apr; 197(4):248-58. PubMed ID: 9254401
    [No Abstract]   [Full Text] [Related]  

  • 18. [Design of a vaccination campaign against hepatitis b virus].
    Canga A; Sanchez M; Fernandez E; Martinez J; Arcos P; Suarez MT
    Rev Sanid Hig Publica (Madr); 1990; 64(3-4):211-7. PubMed ID: 2131602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The clinical characteristics of viral hepatitis B in patients with chronic kidney failure].
    Aripkhodzhaeva FA; Akalaev RN; Nazarov ShN
    Ter Arkh; 1996; 68(11):21-2. PubMed ID: 9045370
    [No Abstract]   [Full Text] [Related]  

  • 20. [Transient blood surface antigens of hepatitis B in patients on hemodialysis].
    Santana Rodríguez OE; Morillas Jarillo C; Esparza Martín N; Toledo González A; Checa Andrés MD; Martín Sánchez AM
    Rev Clin Esp; 1999 Apr; 199(4):198-201. PubMed ID: 10364790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.